Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,132.40
(
0.00%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.71
(
-0.94%
)
Bitcoin
74,017.17
(
0.10%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopearl

Send PM Follow Ignore
Followers 6
Posts 760
Boards Moderated 0
Alias Born 07/18/2006

biopearl

Re: DewDiligence post# 94781

Monday, 04/26/2010 4:58:29 PM

Monday, April 26, 2010 4:58:29 PM

Post# of 257253
Dew (or anyone else knowledgeable), given the current healthcare legislation that is now law, is there clarity regarding biosimilar, biobetter generic drug production? If not, could the FDA delay re MNTA be related to some need for legislative guidance for the agency? Thanks bp
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now